| 2023-05-02 |
详情>>
股本变动：
变动后总股本12237.04万股
|
| 2023-05-02 |
详情>>
业绩披露：
2023年中报每股收益0.16美元,归母净利润1990.00万美元,同比去年增长49.43%
|
| 2023-05-02 |
财报披露：
美东时间 2023-05-02 盘前发布财报
|
| 2023-04-11 |
股东大会：
将于2023-05-11召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to approve the issuance of shares of Xylem’s common stock, par value $0.01 per share (the “Xylem Common Stock”) to the holders of Evoqua Common Stock (the “Evoqua stockholders”), pursuant to the Agreement and Plan of Merger, dated as of January 22, 2023 (as amended from time to time, the “Merger Agreement”), by and among Xylem, Fore Merger Sub, Inc. (“Merger Sub”), and Evoqua Water Technologies Corp. (“Evoqua”), a copy of which is attached as Annex A to the enclosed joint proxy statement/prospectus (the “Share Issuance Proposal”);
2.To consider and vote on a proposal to approve the adjournment of the Xylem Special Meeting, if necessary or appropriate, for the purpose of soliciting additional votes for the approval of the Share Issuance Proposal or to ensure that any supplemental or amended disclosure, including any supplement or amendment to the enclosed joint proxy statement/prospectus, is timely provided to Xylem shareholders (the “Xylem Adjournment Proposal”).
|
| 2023-01-31 |
详情>>
业绩披露：
2023年一季报每股收益0.08美元,归母净利润926.80万美元,同比去年增长54.80%
|
| 2022-12-23 |
股东大会：
将于2023-02-07召开股东大会
会议内容 ▼▲
- 1.Election of Three Class II Director Nominees for Three-Year Terms;
2.Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers;
3.Ratification of the Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending September 30, 2023;
4.Transaction of any other business that may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-11-16 |
详情>>
业绩披露：
2020年年报每股收益0.97美元,归母净利润1.14亿美元,同比去年增长1293.42%
|
| 2022-11-16 |
详情>>
业绩披露：
2022年年报每股收益0.60美元,归母净利润7219.80万美元,同比去年增长40.24%
|
| 2022-08-02 |
详情>>
业绩披露：
2022年三季报(累计)每股收益0.26美元,归母净利润3088.00万美元,同比去年增长25.41%
|
| 2022-05-03 |
详情>>
业绩披露：
2022年中报每股收益0.11美元,归母净利润1331.70万美元,同比去年增长16.11%
|
| 2022-02-01 |
详情>>
业绩披露：
2022年一季报每股收益0.05美元,归母净利润598.70万美元,同比去年增长-6.93%
|
| 2022-02-01 |
详情>>
业绩披露：
2021年一季报每股收益0.05美元,归母净利润643.30万美元,同比去年增长-87.9%
|
| 2022-01-05 |
股东大会：
将于2022-02-16召开股东大会
会议内容 ▼▲
- 1.Election of Three Class I Director Nominees for Three-Year Terms;
2.Approval, on an Advisory Basis, of the Compensation of Our Named Executive Officers;
3.Ratification of the Appointment of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending September 30, 2022;
4.Transaction of any other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-11-17 |
详情>>
业绩披露：
2021年年报每股收益0.43美元,归母净利润5148.20万美元,同比去年增长-54.7%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-08-03 |
详情>>
业绩披露：
2021年三季报(累计)每股收益0.21美元,归母净利润2462.40万美元,同比去年增长-70.1%
|
| 2021-05-05 |
详情>>
业绩披露：
2021年中报每股收益0.10美元,归母净利润1146.90万美元,同比去年增长-81.19%
|
| 2021-01-05 |
股东大会：
将于2021-02-16召开股东大会
会议内容 ▼▲
- 1.To elect four Class III directors, Gary A. Cappeline, Lisa Glatch, Brian R. Hoesterey and Vinay Kumar, to our Board of Directors to hold office until the annual meeting of stockholders for the fiscal year ending September 30, 2023, or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2021;
4.To transact any other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2020-01-06 |
股东大会：
将于2020-02-18召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors, Ron C. Keating, Martin J. Lamb and Peter M. Wilver, to our Board of Directors to hold office until the annual meeting of stockholders for the fiscal year ending September 30, 2022, or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To approve the amendment and restatement of the Evoqua Water Technologies Corp. 2017 Equity Incentive Plan to increase the number of shares of common stock reserved for issuance and incorporate other changes;
4.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2020;
|
| 2019-01-07 |
股东大会：
将于2019-02-14召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors, Nick Bhambri, Judd A. Gregg and Lynn C. Swann, to our Board of Directors to hold office until the annual meeting of stockholders for the fiscal year ending September 30, 2021 or until their successors are duly elected and qualified;
2.To approve, on an advisory basis, the compensation of our named executive officers;
3.To determine, on an advisory basis, the frequency with which stockholders will participate in any advisory vote on executive compensation;
4.To approve the Evoqua Water Technologies Corp. 2018 Employee Stock Purchase Plan;
5.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2019;
6.To transact any other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-11-30 |
详情>>
内部人交易：
Stas Benedict J.等共交易3笔
|